The nation of Zimbabwe has turned down a significant American health deal valued at 367 million US dollars (272 million pounds) spanning five years because of the United States' insistence on sensitive data.
The decision came to light after a official document from December was disclosed, revealing that President Emmerson Mnangagwa felt the arrangement was "skewed".
A government representative has since stated that the United States was demanding access to biological samples for research and profit while refused to share the benefits from future medical innovations.
"We must now begin the difficult and regrettable process of ending our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had furnished over $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has urged continued talks to find a agreement suitable to both sides so the nation's critical HIV treatment initiative can continue.
Wider Context
Zimbabwe's decision follows a similar situation in Kenya, where a high court suspended a related health funding agreement following concerns were raised about the safety of Kenyans' medical information.
After returning to office last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed aid for the American government, but Trump stated its spending was "wasteful" and his administration was pursuing government-to-government deals to enhance transparency and responsibility.
Based on statements, Sixteen African countries have to date agreed to these new agreements, representing more than $18.3bn in new funding.
Details of the Rejected Agreement
This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this collaboration would have delivered extraordinary advantages for Zimbabwean communities, especially the 1.2 million currently receiving antiretroviral therapy via American-funded programmes," Tremont said.
However, government spokesperson Nick Mangwana said the arrangement was "unequal".
"Our nation was requested to share its biological resources and data over an extended period, without any equivalent assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.
"Effectively, our country would provide the raw materials for scientific discovery with no certainty that the final treatments would be accessible to our people should a new pandemic emerge."
National Interest and Global Health
He also pointed out that the US's withdrawal from the global health body and its push of one-on-one health agreements were disrupting systems already set up via the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with future global health emergencies.
"This framework is intended to ensure that when a country provides its samples, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the capability to create them."
Zimbabwe's reservations over the US deal "should not be misconstrued as hostility towards the US," he added.
"We encourage further dialogue with our American counterparts on how future co-operation might be designed in a manner that honours the independence and interests of both nations."
Medical Community Response
A leading public health body stated it understood the official position, but suggested that talks must proceed given that a large portion of the nation's Aids initiatives were funded by international support.
"In cases where technical issues exist, including those involving data governance or agreement terms, these can often be addressed through technical clarification and negotiated safeguards," the group commented.
The halted deal highlights the continuing challenges between accepting much-needed international aid and safeguarding national sovereignty in an increasingly interconnected world.